Genomic biomarkers, androgen pathway and prostate cancer.
about
HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.Genetic tests and genomic biomarkers: regulation, qualification and validationBiomarkers for the diagnosis of new and recurrent prostate cancer.Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy.
P2860
Genomic biomarkers, androgen pathway and prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genomic biomarkers, androgen pathway and prostate cancer.
@en
type
label
Genomic biomarkers, androgen pathway and prostate cancer.
@en
prefLabel
Genomic biomarkers, androgen pathway and prostate cancer.
@en
P2860
P50
P356
P1433
P1476
Genomic biomarkers, androgen pathway and prostate cancer
@en
P2093
Franca D'Amico
Michela Biancolella
P2860
P304
P356
10.2217/14622416.8.6.645
P577
2007-06-01T00:00:00Z